NEW YORK (360Dx) – Concussion test development firm BioDirection today said that it closed $2 million interim financing to support clinical development of its diagnostic system.

Participants in the financing include Provident Healthcare Capital, MedScience Ventures, and others, the Boston-based firm said. In total, BioDirection has raised $12 million in outside funding since its founding in 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.